Literature DB >> 3543223

Neurochemical and immunocytochemical studies on the distribution of N-acetyl-aspartylglutamate and N-acetyl-aspartate in rat spinal cord and some peripheral nervous tissues.

L Ory-Lavollée, R D Blakely, J T Coyle.   

Abstract

HPLC analysis of rat spinal cord revealed a uniform distribution of N-acetyl-aspartate (NAA) across both longitudinal and dorsoventral axes. In contrast, ventral cord N-acetyl-aspartylglutamate (NAAG) levels were significantly higher than those measured in dorsal halves of cervical, thoracic, and lumbar segments. Immunocytochemical studies using an affinity-purified antiserum raised against NAAG-bovine serum albumin revealed an intense staining of motoneurons within rat spinal cord. Along with the considerable NAAG content in ventral roots, these results suggest that NAAG may be concentrated in motoneurons and play a role in motor pathways. NAAG was also present in other peripheral neural tissues, including dorsal roots, dorsal root ganglia, superior cervical ganglia, and sciatic nerve. It is interesting that NAA levels in peripheral nervous tissues were lower than those in CNS structures and that NAA levels in ventral roots and sciatic nerve were lower than NAAG levels. These findings further document a lack of correlation between NAAG and NAA levels in both central and peripheral nervous tissues. Taken together, these data demonstrate the presence of NAAG in nonglutamatergic neuronal systems and suggest a more complex role of NAAG in neuronal physiology than previously postulated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3543223     DOI: 10.1111/j.1471-4159.1987.tb05601.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

Review 1.  Biochemistry and molecular biology of Canavan disease.

Authors:  R Matalon; K Michals-Matalon
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

Review 2.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

3.  N-Acetyl-aspartylglutamate (NAAG) in human cerebrospinal fluid: Determination by high performance liquid chromatography, and influence of biological variables.

Authors:  V Brovia; A Ricciardi; L Barbeito
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

4.  N-acetylaspartic acid (NAA) and N-acetylaspartylglutamic acid (NAAG) in human ventricular, subarachnoid, and lumbar cerebrospinal fluid.

Authors:  K F Faull; R Rafie; N Pascoe; L Marsh; A Pfefferbaum
Journal:  Neurochem Res       Date:  1999-10       Impact factor: 3.996

5.  N-acetylaspartylglutamate synthetase II synthesizes N-acetylaspartylglutamylglutamate.

Authors:  Julia Lodder-Gadaczek; Ivonne Becker; Volkmar Gieselmann; Lihua Wang-Eckhardt; Matthias Eckhardt
Journal:  J Biol Chem       Date:  2011-03-25       Impact factor: 5.157

6.  Aspartoacylase-lacZ knockin mice: an engineered model of Canavan disease.

Authors:  Nadine Mersmann; Dmitri Tkachev; Ruth Jelinek; Philipp Thomas Röth; Wiebke Möbius; Torben Ruhwedel; Sabine Rühle; Wolfgang Weber-Fahr; Alexander Sartorius; Matthias Klugmann
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

7.  Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.

Authors:  Kathryn K Walder; Steve B Ryan; Tomasz Bzdega; Rafal T Olszewski; Joseph H Neale; Clark A Lindgren
Journal:  Eur J Neurosci       Date:  2012-11-08       Impact factor: 3.386

8.  Loss of central auditory processing in a mouse model of Canavan disease.

Authors:  Georg von Jonquieres; Kristina E Froud; Claudia B Klugmann; Ann C Y Wong; Gary D Housley; Matthias Klugmann
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.